Question 1

Does HSBC Holdings own RVNC stock?

Accepted Answer

As of its Q4 2024 13F, HSBC Holdings held 12,111 shares of RVNC (Revance Therapeutics), worth $36,757.

Question 2

How many shares of RVNC does HSBC Holdings own?

Accepted Answer

As of its Q4 2024 13F, HSBC Holdings held 12,111 shares of RVNC (Revance Therapeutics).

Question 3

What is HSBC Holdings' RVNC position worth?

Accepted Answer

As of its Q4 2024 13F, HSBC Holdings' RVNC position was worth $36,757.

Question 4

When did HSBC Holdings first buy RVNC?

Accepted Answer

HSBC Holdings first reported RVNC in its Q2 2021 13F and listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q1 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q4	Decreased	12,111	-99.0%	$36,757	0.0%	—	0
2024-Q3	Increased	1.2M	+7725.4%	$6.2M	0.0%	—	44
2024-Q2	New	14,957	-	$38,486	0.0%	—	31
2023-Q1	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q4	New	19,000	-	$349,586	0.0%	—	33
2022-Q3	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q2	Increased	88,773	+47.7%	$1.2M	0.0%	—	35
2022-Q1	Increased	60,108	+3.6%	$1.2M	0.0%	—	26
2021-Q4	Decreased	58,030	-11.8%	$947,000	0.0%	—	0
2021-Q3	Increased	65,781	+546.3%	$1.8M	0.0%	—	42
2021-Q2	New	10,178	-	$301,000	0.0%	—	32

RVNC12 quarters

RVNC
12 quarters